Home
/
TREACE MEDICAL CONCEPTS, INC.
/
Financials
/
Quarterly
TREACE MEDICAL CONCEPTS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TREACE MEDICAL CONCEPTS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$50.21M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$47.39M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$52.57M
May 8, 2025
Q3
2025
Sep 30, 2024
$45.09M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$44.46M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$51.11M
May 8, 2025
Q3
2024
Sep 30, 2023
$40.76M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$41.95M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$42.20M
May 7, 2024
Q3
2023
Sep 30, 2022
$33.06M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$29.97M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$29.05M
May 9, 2023
Q3
2022
Sep 30, 2021
$21.62M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$20.65M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$18.71M
May 6, 2022
Q3
2021
Sep 30, 2020
$14.27M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$7.74M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$11.26M
May 25, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($16.29M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($17.40M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($17.40M)
Nov 6, 2025
Q2
2025
Mar 31, 2025
($15.92M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($15.92M)
May 8, 2025
Q3
2025
Mar 31, 2025
($15.92M)
Nov 6, 2025
Q3
2025
Sep 30, 2024
($15.36M)
Nov 6, 2025
Q3
2025
Jun 30, 2024
($21.21M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($21.21M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($18.68M)
Nov 6, 2025
Q2
2025
Mar 31, 2024
($18.68M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($18.68M)
May 8, 2025
Q3
2024
Sep 30, 2023
($17.52M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($12.27M)
Aug 6, 2024
Q3
2024
Jun 30, 2023
($12.27M)
Nov 5, 2024
Q2
2024
Mar 31, 2023
($13.45M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($13.45M)
May 7, 2024
Q3
2024
Mar 31, 2023
($13.45M)
Nov 5, 2024
Q3
2023
Sep 30, 2022
($12.13M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($17.23M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.68M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($16.97M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($15.58M)
May 8, 2025
Q3
2025
Sep 30, 2024
($15.13M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($21.38M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($18.97M)
May 8, 2025
Q3
2024
Sep 30, 2023
($17.82M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($13.05M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($13.78M)
May 7, 2024
Q3
2023
Sep 30, 2022
($11.32M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($11.93M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($8.10M)
May 9, 2023
Q3
2022
Sep 30, 2021
($5.46M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($4.05M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($1.40M)
May 6, 2022
Q3
2021
Sep 30, 2020
($63.0K)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($1.52M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($1.20M)
May 25, 2021